
Drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.
Drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.
New Delhi: Indian shares hit fresh all-time highs on Monday, driven by financials and energy stocks as state election results
PSPCL: There has been a 48 per cent reduction in power purchase New Delhi: The Punjab State Power Corporation Ltd
New Delhi: Nifty hit a fresh record high on Friday, as faster-than-expected economic growth in the September-quarter added to optimism
There is high demand for critical and strategic minerals. (Representational) New Delhi: The government on Wednesday said 125 new projects
New Delhi: NDTV Profit, the business news channel of the New Delhi Television Ltd, is set to resume regular operations
Bitcoin gained around 1.5% on Friday to trade above USD 38,000. (Representational) Bitcoin, the world’s most prominent cryptocurrency, surged past
Patanjali has denied it ever made any false claims in ads (File) New Delhi: Yoga teacher Ramdev-led Patanjali Ayurved on
RBI Governor asked entities to be “judicious” in using flexibility on the interest rates. Mumbai: Stating that some Non Banking
Trai is fixing bugs in its do not disturb app. (Representational) New Delhi: The Telecom Regulatory Authority of India (Trai)
The central bank expects inflation to average 5.4% in 2023-24. Mumbai: India is not home-free with regards to the pressures